☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
VistaGen
Vistagen Reports Positive Results from P-IIa Study of PH15 for Improvement of Psychomotor Impairment
April 26, 2024
Vistagen Reports P-III Trial (PALISADE-2) Results of Fasedienol (PH94B) Nasal Spray for Social Anxiety Disorder
August 8, 2023
Insights+: COVID-19 Healthcare News Monthly Updates - April 2020
January 5, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.